Scorpion Therapeutics, Inc, a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, announced...
PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that Nick Anderson, Ph.D, has joined as Vice President of Regulatory...
Guardant Health, Inc., a leading precision oncology company, announced positive results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode),...
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced the completion of a $35 million Series C funding...
